Understand key differences between THC, CBD, and synthetic THC to help employers manage workplace drug testing and compliance risks.

Learn how to develop and implement a corporate drug testing program that enhances workplace safety, ensures compliance, and supports a drug-free environment.

Discover highlights from Day with DISA 2019, an employee screening conference focused on compliance, safety, and workforce risk management.

Get to know the expert speakers at Day with DISA. Learn from industry leaders on workforce compliance, drug testing, and background screening trends.

Stay compliant with DOT drug and alcohol regulations. Learn testing requirements, employer responsibilities, and key updates for workforce safety.

Learn about the FDA and DEA's review of marijuana-derived drugs and potential reclassification to Schedule II or III substances.

Explore how changing marijuana laws impact drug testing and discover strategies to help employers stay compliant and manage risk.

Review DISA’s most impactful 2018 articles on workplace safety, compliance trends, and drug testing policies for employers.

Learn about Nevada’s updated marijuana testing law and how it impacts pre-employment drug testing and employer compliance.

Learn how California’s AB 2188 impacts employer cannabis policies, CBD use concerns, and multistate drug testing compliance.

State status reflects current laws at the time of update, not pending legislation or future dates upon which marijuana becomes available medicinally or recreationally. States with legislation that has passed but has a future enactment date will be marked with an asterisk *.CBD oil can be made with or without THC.

Learn the key 2026 DOT compliance updates for motor carriers, including drug testing changes, Clearinghouse enforcement, medical certification rules, and FMCSA reforms.

Learn how the federal Delta-8 and THCA ban impacts workplace drug testing, compliance, and employer policies. Prepare for 2026 changes.